Rubella

The History of Vaccine Mandates in the US Military, States, and Public Schools Dates Back Over 200 Years, per the A-Mark Foundation

Thursday, October 14, 2021 - 1:55pm

There is also coverage of opposition to vaccine mandates throughout history, and an informative chart showing the vaccine requirements and exemptions for K-12 public schools in all 50 states.

Key Points: 
  • There is also coverage of opposition to vaccine mandates throughout history, and an informative chart showing the vaccine requirements and exemptions for K-12 public schools in all 50 states.
  • We also found that all 50 states currently require vaccinations for viruses such as polio, measles, and rubella for students in K-12 public schools."
  • While all 50 states have had mandated vaccine requirements since 1980 or earlier, there are some exemptions allowed.
  • "We hope that our report will add to available information on vaccine mandates, which should allow people to make more informed decisions about this contentious issue."

Accesa Labs, symplr Announce Integrated Solution to Streamline and Strengthen the Vendor Credentialing Process

Wednesday, September 29, 2021 - 11:00am

Typically, credentialing can be a slow and inefficient process involving phone calls and emails with doctor's offices, paperwork, and uncertain costs.

Key Points: 
  • Typically, credentialing can be a slow and inefficient process involving phone calls and emails with doctor's offices, paperwork, and uncertain costs.
  • Accesa Labs technology automates this process by enabling vendor reps to order tests and services at guaranteed prices from more than 3,000 approved testing locations nationwide.
  • "Vendor credentialing has long played an important role in protecting patients and minimizing business risks for healthcare organizations.
  • Partnering with Accesa Labs accelerates the entire process by quickly green-lighting compliant vendors for access," said Peggy Drew, Sr. Director, Product Management at symplr.

Walmart and Sam’s Club Now Administering Booster Shots

Friday, September 24, 2021 - 7:15pm

Walmart and Sams Club are now administering Pfizer booster shots in more than 5,100 pharmacies around the country where supply allows.

Key Points: 
  • Walmart and Sams Club are now administering Pfizer booster shots in more than 5,100 pharmacies around the country where supply allows.
  • Walk-In Availability: Walmart and Sams Club have walk-in availability to encourage people to get vaccinated and get their booster shot during their regularly scheduled shopping trips.
  • Walmart also provides COVID-19 testing at select locations, and both Walmart and Sams Club offer over-the-counter medications and low-cost, healthy grocery foods.
  • To learn more about wellness resources available at your neighborhood Walmart, please visit walmart.com/wellnesshub or at Sams Club at samsclub.com .

Columbus Metropolitan Housing Authority is the latest Ohio employer to announce a vaccination requirement, helping agency achieve a 90% compliance rate

Wednesday, September 1, 2021 - 2:03pm

Columbus, OH, Sept. 01, 2021 (GLOBE NEWSWIRE) -- The Columbus Metropolitan Housing Authority (CMHA) announced it began implementation of a mandatory vaccination policy for all employees that became effective Monday, Aug. 30, 2021, helping the agency reach a 90% immunization compliance rate.

Key Points: 
  • Columbus, OH, Sept. 01, 2021 (GLOBE NEWSWIRE) -- The Columbus Metropolitan Housing Authority (CMHA) announced it began implementation of a mandatory vaccination policy for all employees that became effective Monday, Aug. 30, 2021, helping the agency reach a 90% immunization compliance rate.
  • CMHA is providing a cash incentive for all 120-plus staff members who receive the vaccine within the agencys identified timeline.
  • CMHAs introduction of the vaccination requirement follows similar announcements by numerous colleges, national retailers and other Ohio businesses that have begun to mandate vaccines.
  • Half of the authority's apartments are set aside as workforce housing for families earning 80% of the area median income.

Walmart Makes It Easy to Stay Healthy with Convenient Flu Shots, Now Available Nationwide

Wednesday, August 18, 2021 - 4:00pm

Low-cost flu shots are now available in 4,600+ Walmart pharmacies nationwide via walk-up and community flu shot clinics.

Key Points: 
  • Low-cost flu shots are now available in 4,600+ Walmart pharmacies nationwide via walk-up and community flu shot clinics.
  • Walmart pharmacies across the country offer both vaccines, and customers can receive a low-cost flu and free COVID-19 vaccine at the same time, if they choose.
  • These events will make it quick, easy and convenient for customers to get flu shots in stores nationwide.
  • To learn more about the flu shots and wellness resources available at your neighborhood Walmart, please visit www.walmart.com/wellnesshub .

Universities and Colleges Prepare for the Safe Return to Campus this Fall with Kokomo24/7® Safety Cloud™ to Manage COVID-19 Vaccinations of Students, Staff, and Faculty

Wednesday, August 11, 2021 - 3:45pm

Part of the Kokomo24/7 Safety Cloud, VaxTrax serves as a tool for accurate and secure vaccination data collection and management, as well as verification and digital proof accessibility.

Key Points: 
  • Part of the Kokomo24/7 Safety Cloud, VaxTrax serves as a tool for accurate and secure vaccination data collection and management, as well as verification and digital proof accessibility.
  • It allows an institution to efficiently compile and manage all vaccine information belonging to students, staff, and faculty.
  • The process from uploading vaccine information to receiving a verified, digital vaccine card is quick and seamless.
  • At present, nearly 1 million users have utilized one of the many health and safety features of the Kokomo24/7 Safety Cloud.

Statement from the Chief Public Health Officer of Canada on June 16, 2021

Wednesday, June 16, 2021 - 7:14pm

The region of the Americas is currently the only World Health Organization (WHO) region to have obtained the elimination status for measles, rubella and CRS.

Key Points: 
  • The region of the Americas is currently the only World Health Organization (WHO) region to have obtained the elimination status for measles, rubella and CRS.
  • At the same time, the Public Health Agency of Canada is providing Canadians with regular updates on COVID-19 vaccines administered , vaccination coverage and ongoing monitoring of vaccine safety across the country.
  • As immunity is still building up across the population, public health measures and individual precautions remaincrucial for COVID-19 control.
  • Working together, Health Canada , the Public Health Agency of Canada , the National Advisory Committee on Immunization , Canada's Chief Medical Officers of Health and other health professionals across the country are closely monitoring vaccine safety , effectiveness and optimal use to adapt approaches.

Enesi Pharma Achieves Key Milestone in Development of Thermostable Solid-dose Live Vaccines against Measles and Rubella

Wednesday, May 5, 2021 - 8:00am

b'OXFORD, England, May 5, 2021 /PRNewswire/ -- Enesi Pharma ("Enesi"), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax technologies,announces it has achieved a key milestone in its project to develop needle-free thermostable unit solid-dose live vaccines with retained activity against Measles and Rubella.

Key Points: 
  • b'OXFORD, England, May 5, 2021 /PRNewswire/ -- Enesi Pharma ("Enesi"), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax technologies,announces it has achieved a key milestone in its project to develop needle-free thermostable unit solid-dose live vaccines with retained activity against Measles and Rubella.
  • Once reconstituted, however, the vaccines exhibit very poor thermal stability and rapidly lose effectiveness if not refrigerated.
  • These results are establishing preclinical proof-of-concept for ImplaVax-enabled solid dose forms of vaccines based on many of the major current formats in use today.
  • "\nMeasles remains one of the leading causes of childhood mortality leading to an estimated 450 deaths each day worldwide, according to the World Health Organization.

Enesi Pharma Achieves Key Milestone in Development of Thermostable Solid-dose Live Vaccines against Measles and Rubella

Wednesday, May 5, 2021 - 8:00am

b'OXFORD, England, May 5, 2021 /PRNewswire/ -- Enesi Pharma ("Enesi"), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax technologies,announces it has achieved a key milestone in its project to develop needle-free thermostable unit solid-dose live vaccines with retained activity against Measles and Rubella.

Key Points: 
  • b'OXFORD, England, May 5, 2021 /PRNewswire/ -- Enesi Pharma ("Enesi"), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax technologies,announces it has achieved a key milestone in its project to develop needle-free thermostable unit solid-dose live vaccines with retained activity against Measles and Rubella.
  • Once reconstituted, however, the vaccines exhibit very poor thermal stability and rapidly lose effectiveness if not refrigerated.
  • These results are establishing preclinical proof-of-concept for ImplaVax-enabled solid dose forms of vaccines based on many of the major current formats in use today.
  • "\nMeasles remains one of the leading causes of childhood mortality leading to an estimated 450 deaths each day worldwide, according to the World Health Organization.

Aalto Bio Launches Breakthrough Rubella Diagnostic Material

Tuesday, February 2, 2021 - 2:00pm

DUBLIN, Feb. 2, 2021 /PRNewswire/ -- Aalto Bio Reagents is pleased to announce the availability of the first highly reactive recombinant Rubella Spike Ectodomain (E1-E2) antigen, code BM 6428, which has shown exceptional detection of both IgG and IgM antibodies in ELISA and bead-based immunoassays.

Key Points: 
  • DUBLIN, Feb. 2, 2021 /PRNewswire/ -- Aalto Bio Reagents is pleased to announce the availability of the first highly reactive recombinant Rubella Spike Ectodomain (E1-E2) antigen, code BM 6428, which has shown exceptional detection of both IgG and IgM antibodies in ELISA and bead-based immunoassays.
  • Using the protein sequence from the Rubella vaccine strain HPV-77, Aalto Bio Reagents was able to produce a very reliable product, ready for use in the development of highly specific IgG and IgM assays.
  • Transmitted by droplets, Rubella continues to be a widespread infection, particularly in areas where vaccination rates are low.
  • Founded in 1978, Aalto Bio Reagents is a leading developer and provider of raw materials to the in- vitro diagnostics industry and to research laboratories globally.